Related Experiment Video
Updated: Jan 27, 2026

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
Published on: June 13, 2021
Group Prenatal Care for Women Receiving Medication-Assisted Treatment for Opioid Use Disorder in Pregnancy: An
Mary Beth Sutter1, Hannah Watson2, Ariele Bauers3
1Department of Family and Community Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania.
Abstract:
Opioid use disorder among pregnant women is common and rapidly increasing nationwide. Group prenatal care is an innovative alternative to individual care for pregnant women and has been shown to improve women's and health care providers' satisfaction and adherence to care. We describe a novel group prenatal care program colocated in an opioid treatment program that integrates prenatal care, substance use disorder counseling, and medication-assisted treatment. Our interprofessional model draws on the unique contributions of physicians, midwives, nurses, and mental health professionals to address the complex needs of pregnant women with opioid use disorder. Participants reported increased trust and engagement with health care providers and peers, improved prenatal care and birth experience, and increased resilience for relapse prevention. Group prenatal care is an accepted and promising model for women with opioid use disorder in pregnancy and has the potential to improve outcomes for women and newborns.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Aneurysm III: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Acute Kidney Injury V: Interprofessional Care
Chronic Kidney Disease III: Interprofessional Care

